关键词：癌症测试；筛查；治疗措施；避免癌细胞；体内扩散；基因测试分析
摘 要：Cancer testing or screening is done for the early detection of cancer, enabling effective treatment measures to avoid spreading of cancerous cells throughout the body. The testing procedure involves testing of samples such as urine, blood, and other bodily substances. Further, cancer testing also involves conducting genetic tests to analyze certain gene mutations which are linked to certain cancer types. The types of cancer tests performed are biopsy, colonoscopy, pap test, and fecal occult blood tests.
目 录：

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: US healthcare reform

Impact of US healthcare reform on cancer testing

industry

PART 06: Reimbursement and coverage: an overview

Current scenario: validating diagnostic tests

Reimbursement structure in the US

Prevailing issues of reimbursement policies

PART 07: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 08: Market segmentation by technique

Breast cancer

Colorectal cancer

Prostate cancer

Other

PART 09: Market drivers

PART 10: Impact of drivers

PART 11: Market challenges

PART 12: Impact of drivers and challenges

PART 13: Market trends

PART 14: Vendor landscape

Competitive scenario

Market share analysis 2014

Other prominent vendors

PART 15: Key vendor analysis

Abbott Diagnostics

Agilent Technologies

Beckman Coulter

Roche Diagnostics

PART 16: Appendix

List of abbreviations

PART 17: Explore Technavio